Ifosfamide is a commonly used chemotherapeutic known to have numerous adverse kidney manifestations. In this issue of , Ensergueix report a multicentric observational retrospective French study on 34 adult patients with tubular dysfunction and /or kidney dysfunction following ifosfamide treatment. Of these patients, 18% had isolated proximal tubular dysfunction, 14% had isolated acute kidney injury (AKI), 18% had isolated chronic kidney disease (CKD) and 50% had a combination of proximal tubular dysfunction and AKI.
View Article and Find Full Text PDF